PKM2, the “K⁺ sink” in the tumor interstitial fluid

References

[1] Butler TP , Grantham FH , Gullino PM . Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res 1975; 35: 3084- 3088.

[2] Chen S , Cui W , Chi Z et al. Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1. Cell Metab 2022; 34: 1843- 1859.e11.

[3] Christofk HR , Vander Heiden MG , Harris MH et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230- 233.

[4] Cox TR . The matrix in cancer. Nat Rev Cancer 2021; 21: 217- 238.

[5] Di Martino JS , Akhter T , Bravo-Cordero JJ . Remodeling the ECM: implications for metastasis and tumor dormancy. Cancers (Basel) 2021; 13: 4916.

[6] Eil R , Vodnala SK , Clever D et al. Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 2016; 537: 539- 543.

[7] Freitas I , Baronzio GF , Bono B et al. Tumor interstitial fluid: misconsidered component of the internal milieu of a solid tumor. Anticancer Res 1997; 17: 165- 172.

[8] Fukumura D , Jain RK . Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 2007; 101: 937- 949.

[9] Gavriilidou AFM , Holding FP , Mayer D et al. Native mass spectrometry gives insight into the allosteric binding mechanism of M2 pyruvate kinase to fructose-1,6-bisphosphate. Biochemistry 2018; 57: 1685- 1689.

[10] Giussani M , Triulzi T , Sozzi G et al. Tumor extracellular matrix remodeling: new perspectives as a circulating tool in the diagnosis and prognosis of solid tumors. Cells 2019; 8: 81.

[11] Hanahan D , Coussens LM . Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309- 322.

[12] He D , Feng H , Sundberg B et al. Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Mol Cell 2022; 82: 3045- 3060.e11.

[13] Henke E , Nandigama R , Ergun S . Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci 2019; 6: 160.

[14] Joyce JA , Fearon DT . T cell exclusion, immune privilege, and the tumor microenvironment. Science 2015; 348: 74- 80.

[15] Lunt SJ , Fyles A , Hill RP et al. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 2008; 4: 793- 802.

[16] Poltavets V , Kochetkova M , Pitson SM et al. The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front Oncol 2018; 8: 431.

[17] Schormann N , Hayden KL , Lee P et al. An overview of structure, function, and regulation of pyruvate kinases. Protein Sci 2019; 28: 1771- 1784.

[18] Vodnala SK , Eil R , Kishton RJ et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 2019; 363: eaau0135.

[19] Wagner M , Wiig H . Tumor interstitial fluid formation, characterization, and clinical implications. Front Oncol 2015; 5: 115.

[20] Wang P , Sun C , Zhu T et al. Structural insight into mechanisms for dynamic regulation of PKM2. Protein Cell 2015; 6: 275- 287.

[21] Wiig H , Tenstad O , Iversen PO et al. Interstitial fluid: the overlooked component of the tumor microenvironment? Fibrogenesis Tissue Repair 2010; 3: 12.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.